Open-house rebate agreements for Tocilizumab
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tocilizumab, ATC L04AC07
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
Paper submissions require two original signed copies and timely receipt of the originals by the 10th of the month after...
Participation is limited to pharmaceutical companies and requires a signed declaration of reliability.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Dec 2026
- Non-exclusive supply/rebate agreement for Tocilizumab, ATC L04AC07.
- Open-house model with identical, non-individually negotiable contract terms.
Show full summary
This is an open-house pharmaceutical supply arrangement for Tocilizumab (ATC L04AC07) offered by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. The contract can start from 2025-01-01, runs until 2026-12-31, and applications can be submitted until 2026-11-05 11:00. No contract value is stated.
Risks
Paper submissions require two original signed copies and timely receipt of the originals by the 10th of the month after...
Participation is limited to pharmaceutical companies and requires a signed declaration of reliability.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible as potential contract partners.
Administrative
- Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open-house rebate agreements for Tocilizumab
Single lot covering non-exclusive open-house rebate agreements for the pharmaceutical product Tocilizumab, ATC L04AC07. The lot is for supplies in Germany, with performance in Bavaria (DE212). The procedure is open-house, with no selection among bidders and identical contract terms for all eligible pharmaceutical companies. Lot information comes from structured data and the XML notice.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Tocilizumab, ATC L04AC07
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 17 Nov 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 701022-2024
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
Paper submissions require two original signed copies and timely receipt of the originals by the 10th of the month after...
Participation is limited to pharmaceutical companies and requires a signed declaration of reliability.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications